nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.261	0.363	CbGbCtD
Ximelagatran—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.261	0.363	CbGbCtD
Ximelagatran—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.198	0.275	CbGbCtD
Ximelagatran—F2—leg—chronic obstructive pulmonary disease	0.0369	0.625	CbGeAlD
Ximelagatran—F2—Common Pathway—SERPINE2—chronic obstructive pulmonary disease	0.0189	0.0858	CbGpPWpGaD
Ximelagatran—F2—Intrinsic Pathway—SERPINE2—chronic obstructive pulmonary disease	0.0161	0.073	CbGpPWpGaD
Ximelagatran—F2—Formation of Fibrin Clot (Clotting Cascade)—SERPINE2—chronic obstructive pulmonary disease	0.0109	0.0493	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—RAPGEF3—chronic obstructive pulmonary disease	0.00928	0.0421	CbGpPWpGaD
Ximelagatran—F2—respiratory system—chronic obstructive pulmonary disease	0.00916	0.155	CbGeAlD
Ximelagatran—F2—connective tissue—chronic obstructive pulmonary disease	0.00806	0.137	CbGeAlD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—TLR2—chronic obstructive pulmonary disease	0.00579	0.0263	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.00579	0.0263	CbGpPWpGaD
Ximelagatran—F2—lung—chronic obstructive pulmonary disease	0.00486	0.0825	CbGeAlD
Ximelagatran—F2—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00471	0.0214	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00453	0.0206	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00421	0.0191	CbGpPWpGaD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—MMP1—chronic obstructive pulmonary disease	0.0042	0.0191	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00412	0.0187	CbGpPWpGaD
Ximelagatran—F2—Blood Clotting Cascade—PLAU—chronic obstructive pulmonary disease	0.00397	0.018	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.00388	0.0176	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00374	0.017	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—SERPINA1—chronic obstructive pulmonary disease	0.00367	0.0167	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00329	0.0149	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00316	0.0143	CbGpPWpGaD
Ximelagatran—F2—Blood Clotting Cascade—SERPINE1—chronic obstructive pulmonary disease	0.00307	0.014	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.003	0.0136	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—PLAUR—chronic obstructive pulmonary disease	0.00257	0.0117	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00251	0.0114	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IL1B—chronic obstructive pulmonary disease	0.00233	0.0106	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00222	0.0101	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—MMP9—chronic obstructive pulmonary disease	0.0022	0.00997	CbGpPWpGaD
Ximelagatran—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00218	0.00988	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—MUC5AC—chronic obstructive pulmonary disease	0.00217	0.00986	CbGpPWpGaD
Ximelagatran—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00209	0.00951	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.00204	0.00927	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—MUC1—chronic obstructive pulmonary disease	0.00185	0.00838	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—PLAU—chronic obstructive pulmonary disease	0.0018	0.00819	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.00176	0.008	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—MMP9—chronic obstructive pulmonary disease	0.00174	0.00792	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—NOS3—chronic obstructive pulmonary disease	0.00172	0.00779	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00166	0.00755	CbGpPWpGaD
Ximelagatran—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00158	0.00718	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00157	0.00712	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ALB—chronic obstructive pulmonary disease	0.00157	0.00711	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00153	0.00695	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—NOS3—chronic obstructive pulmonary disease	0.00152	0.00691	CbGpPWpGaD
Ximelagatran—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00152	0.00691	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00142	0.00646	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—SERPINE1—chronic obstructive pulmonary disease	0.0014	0.00634	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00132	0.00599	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00131	0.00595	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00128	0.00579	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00128	0.00579	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.00127	0.00579	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.00127	0.00578	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—MMP1—chronic obstructive pulmonary disease	0.00122	0.00552	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00114	0.0052	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00111	0.00502	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00105	0.00475	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.00104	0.00471	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.00103	0.00468	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00103	0.00466	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.00101	0.0046	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.00101	0.00459	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—chronic obstructive pulmonary disease	0.00094	0.00426	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000925	0.0042	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000925	0.0042	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000904	0.0041	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000892	0.00405	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000876	0.00398	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000869	0.00395	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000858	0.0039	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000824	0.00374	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000782	0.00355	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000778	0.00353	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—PLAUR—chronic obstructive pulmonary disease	0.000764	0.00347	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000761	0.00345	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00076	0.00345	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000752	0.00342	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000746	0.00339	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000733	0.00333	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00068	0.00309	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000663	0.00301	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000658	0.00298	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000657	0.00298	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000648	0.00294	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000644	0.00292	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000641	0.00291	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000607	0.00276	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000598	0.00271	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000576	0.00261	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.00057	0.00259	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000548	0.00249	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000533	0.00242	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000511	0.00232	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000504	0.00229	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000498	0.00226	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000491	0.00223	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000485	0.0022	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000485	0.0022	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000482	0.00219	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000469	0.00213	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000464	0.00211	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000463	0.0021	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000461	0.00209	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000442	0.00201	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000438	0.00199	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	0.000412	0.00187	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000404	0.00183	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000401	0.00182	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000389	0.00177	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000388	0.00176	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000384	0.00174	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000384	0.00174	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000363	0.00165	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000334	0.00152	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00033	0.0015	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000329	0.00149	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000325	0.00147	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000323	0.00147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00032	0.00145	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000311	0.00141	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000307	0.00139	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000306	0.00139	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000298	0.00135	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000297	0.00135	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000294	0.00134	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000294	0.00134	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00128	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00127	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000277	0.00126	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000259	0.00118	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000252	0.00114	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000251	0.00114	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.00025	0.00114	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—chronic obstructive pulmonary disease	0.00025	0.00113	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000248	0.00112	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000239	0.00108	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000237	0.00108	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000237	0.00108	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000236	0.00107	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000228	0.00103	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000225	0.00102	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000217	0.000984	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000197	0.000893	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000173	0.000787	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000172	0.000781	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000167	0.000757	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000162	0.000737	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000161	0.000732	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000158	0.000717	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000151	0.000684	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.000679	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000149	0.000675	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	0.000147	0.000666	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000136	0.000619	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000134	0.000608	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000133	0.000603	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—chronic obstructive pulmonary disease	0.00013	0.00059	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000122	0.000552	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000121	0.000548	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000116	0.000528	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.000493	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000108	0.000491	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.89e-05	0.000403	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.48e-05	0.000385	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.1e-05	0.000368	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.01e-05	0.000364	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.92e-05	0.000359	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.38e-05	0.000335	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.23e-05	0.000328	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.18e-05	0.000326	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.83e-05	0.00031	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.66e-05	0.000302	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.5e-05	0.000295	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.83e-05	0.000265	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.55e-05	0.000252	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.48e-05	0.000249	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.36e-05	0.000243	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.25e-05	0.000238	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.1e-05	0.000232	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.84e-05	0.00022	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.41e-05	0.0002	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.04e-05	0.000183	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.29e-05	0.000149	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.15e-05	0.000143	CbGpPWpGaD
